|
Engraftment of murine breast cancer cells into BALB/C mice |
|||
| Tumors/injections |
|||
|
|
|||
| 1000 |
100 |
1 |
|
|
|
|||
| Mice with normal immune function |
|||
| Cells treated with 0.35 PPC of TE |
7/7 |
7/7 |
1/10 |
| CD44+CD24+ cells |
0/7 |
0/7 |
- |
| CD44+CD24- cells |
7/7 |
5/7 |
0/7 |
| Mice with suppressed immune function |
|||
| Cells treated with 0.35 PPC of TE |
7/7 |
7/7 |
2/10 |
| CD44+CD24+ cells |
0/7 |
0/7 |
- |
| CD44+CD24- cells |
7/7 |
7/7 |
0/7 |
Li et al. BMC Cancer 2008 8:135 doi:10.1186/1471-2407-8-135 |
|||